Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

People

David J.
Kappos

Partner, Corporate

dkappos@cravath.com
  • New York+1-212-474-1168
    • E-mail
    • Twitter
    • Facebook
    • LinkedIn
  • PDF
  • Vcard
  • Overview
  • Credentials
  • Featured Work
  • News & Insights

David J. Kappos is Co-Chair of the Intellectual Property Practice. He is widely recognized as one of the world’s foremost leaders in the field of intellectual property, including intellectual property management and strategy, the development of global intellectual property norms, laws and practices as well as commercialization and enforcement of innovation‑based assets. Mr. Kappos supports Cravath’s clients with a wide range of their most complex intellectual property issues, including those pertaining to blockchain, cryptoassets and fintech, as well as cybersecurity and data privacy.

From August 2009 to January 2013, Mr. Kappos served as Under Secretary of Commerce and Director of the United States Patent and Trademark Office (USPTO). In that role, he advised the President, the Secretary of Commerce and the Administration on intellectual property policy matters. As Director of the USPTO, he led the Agency in dramatically re‑engineering its entire management and operational systems as well as its engagement with the global innovation community. He was instrumental in achieving the greatest legislative reform of the U.S. patent system in generations through passage and implementation of the Leahy‑Smith America Invents Act, signed into law by President Obama in September 2011.

Prior to leading the USPTO, Mr. Kappos held several executive posts in the legal department of IBM, including litigation counsel, Asia Pacific IP counsel and, from 2003 to 2009, Vice President and Chief Intellectual Property Lawyer responsible for all patent, trademark, copyright and trade secret matters worldwide. 

Mr. Kappos’s notable matters include representing:

  • Disney in its $85 billion acquisition of 21st Century Fox;
  • Mylan in its $50 billion combination with Upjohn, a division of Pfizer, to form Viatris, and Viatris in its divestitures totaling $6.94 billion in value, including the $3.335 billion combination of its biosimilars portfolio with Biocon Biologics and the divestitures of its Over‑the‑Counter, Women’s Healthcare and Active Pharmaceutical Ingredients businesses, and in its global research and development collaboration with Idorsia;
  • AerCap in its $30 billion acquisition of GE Capital Aviation Services from General Electric;
  • Paramount’s special committee in the $28 billion merger with Skydance;
  • Amazon in its $8.45 billion acquisition of MGM;
  • Brookfield Renewable in its strategic partnership with Cameco to acquire Westinghouse for $8 billion;
  • Illumina in its $8 billion acquisition and subsequent spin‑off of GRAIL, its pending acquisition of SomaLogic and its previous co-development agreement with SomaLogic;
  • Biogen in its $7.3 billion acquisition of Reata Pharmaceuticals, its $1.25 billion settlement and license agreement with Forward Pharma, the expansion of its existing agreement with Eisai to jointly develop and commercialize investigational Alzheimer’s disease treatments and its strategic collaboration agreement with Skyhawk;
  • AmerisourceBergen in its $6.5 billion acquisition of Walgreens’ Alliance Healthcare businesses;
  • Johnson & Johnson in the separation of Kenvue and its $6.5 billion acquisition of Momenta;
  • Scientific Games in the $6.05 billion sale of SG Lottery to Brookfield;
  • The Snyder family in the $6.05 billion sale of the NFL’s Washington Commanders to a partnership led by Josh Harris;
  • HCSC in its $3.3 billion acquisition of Cigna’s Medicare businesses and CareAllies;
  • Roivant Sciences in its $3 billion Strategic Alliance with Sumitomo Dainippon Pharma;
  • The Aquarion Water Authority in its pending $2.4 billion acquisition of Aquarion Water Company from Eversource Energy;
  • WiseTech Global in its $2.1 billion acquisition of e2open, its $414 million acquisition of Blume Global from funds managed by Apollo and EQT and its $230 million acquisition of Envase Technologies from Firmament;
  • Prosus in its $1.8 billion acquisition of Stack Overflow;
  • Bridge Investment Group’s special committee in the pending $1.5 billion acquisition by Apollo;
  • DMGT in the £1.425 billion sale of RMS to Moody's;
  • Paragon 28 in its $1.2 billion acquisition by Zimmer Biomet;
  • Hailey Bieber in the $1 billion acquisition of rhode by e.l.f. Beauty;
  • Light & Wonder in its $850 million acquisition of Grover Charitable Gaming;
  • ZimVie in its pending $730 million acquisition by ARCHIMED and the $375 million sale of its spine business to H.I.G. Capital;
  • Hasbro in the $500 million sale of its eOne Film and TV Business to Lionsgate and in the $385 million sale of eOne Music to Blackstone;
  • Intermex’s strategic alternatives committee in the pending $500 million acquisition by Western Union;
  • Technicolor in the $475 million sale of its Patent Licensing business to InterDigital;
  • Robinhood in its IPO and its $300 million acquisition of TradePMR;
  • Aramex in its $265 million acquisition of MyUS;
  • DRI Capital in the acquisition of a synthetic royalty interest in the worldwide sales of sebetralstat and related equity investment in KalVista Pharmaceuticals, the acquisition from Editas Medicine of payment streams based on the Cas9 gene‑editing technology for CASGEVY, its acquisition of a royalty interest in Orserdu from Eisai, its acquisition of a second royalty interest in Orserdu from Radius Health and the $210 million sale of its TZIELD royalty interest to Sanofi;
  • Ashland in the sale of its nutraceuticals business to Turnspire Capital Partners;
  • Blue Current in its investment from Koch Strategic Platforms;
  • CardWorks in its acquisition of Ally’s credit card business;
  • Costamare in the spin-off of Costamare Bulkers;
  • Fitch Learning, a subsidiary of Hearst, in its pending acquisition of Moody’s Analytics Learning Solutions and the Canadian Securities Institute;
  • Just Eat Takeaway.com in the sale of Grubhub to Wonder;
  • Montana Technologies in its joint venture with GE Vernova;
  • Pitney Bowes in the sale of Borderfree to Global‑e;
  • Qualcomm in the commercial terms of its settlement of global litigation with Apple, including a global six‑year patent license agreement and a multiyear chipset supply agreement;
  • Quibi in its sale to Roku;
  • RedHill Biopharma in its acquisition of Movantik from AstraZeneca and in its agreement with HealthCare Royalty to extinguish its debt obligations in exchange for Movantik;
  • RELX Group in its acquisition of Interfolio; and
  • Taro in its acquisition of Alchemee, formerly The Proactiv Company, from Galderma.

Mr. Kappos has received numerous accolades for his contributions to the field of intellectual property, including, among others, the 2014 Global Agenda Council Vision Award for the Intellectual Property Council’s pro bono initiative from the World Economic Forum, the 2014 Jefferson Medal from the New Jersey Intellectual Property Law Association (NJIPLA), the 2013 Board of Director’s Excellence Award from the American Intellectual Property Law Association (AIPLA), the 2013 Champion of Intellectual Property Award from the District of Columbia Bar Association and the 2013 North America Government Leadership Award from Semiconductor Equipment and Materials International (SEMI). He was also honored as the inaugural recipient of IPWatchdog’s Paul Michel Award in 2021. Mr. Kappos was named one of the “Top 25 Icons of IP” by Law360, one of the “50 Most Influential People in Intellectual Property” and the “Outstanding Practitioner of the Year in IP Transactions” by Managing IP, one of the “Top 50 Intellectual Property Trailblazers & Pioneers” and one of the “100 Most Influential Lawyers in America” by The National Law Journal, “Intellectual Property Professional of the Year” by the Intellectual Property Owners Association and inducted into the Intellectual Property Hall of Fame by Intellectual Asset Management Magazine in 2012. Mr. Kappos was also recognized as a leading lawyer by IAM Global Leaders, IAM Strategy 300, IAM Patent 1000, World IP Review, Chambers USA, The Legal 500 US, Who’s Who Legal: Patents, LMG Life Sciences, Lawdragon, Super Lawyers and The Best Lawyers in America. He is a frequent speaker and has authored many published articles on various intellectual property, innovation and leadership topics.

Mr. Kappos serves on the Boards of Directors of the Partnership for Public Service, the Center for Global Enterprise and the Intellectual Property Owners Education Foundation and on the Advisory Board for C‑IP2. He is the Chair of the Advisory Council of the Naples Roundtable and is a Co‑Chair of the Best Practices in Intellectual Property Conference. He is also an Adjunct Professor at Cornell Law School, where he co‑teaches a class entitled “High Growth Transactions.”

Mr. Kappos was born in Palos Verdes, California. He received a B.S. summa cum laude in Electrical and Computer Engineering from the University of California, Davis in 1983 and a J.D. from the University of California, Berkeley in 1990.

From August 2009 to January 2013, Mr. Kappos served as Under Secretary of Commerce and Director of the United States Patent and Trademark Office (USPTO). In that role, he advised the President, the Secretary of Commerce and the Administration on intellectual property policy matters. As Director of the USPTO, he led the Agency in dramatically re‑engineering its entire management and operational systems as well as its engagement with the global innovation community. He was instrumental in achieving the greatest legislative reform of the U.S. patent system in generations through passage and implementation of the Leahy‑Smith America Invents Act, signed into law by President Obama in September 2011.

Prior to leading the USPTO, Mr. Kappos held several executive posts in the legal department of IBM, including litigation counsel, Asia Pacific IP counsel and, from 2003 to 2009, Vice President and Chief Intellectual Property Lawyer responsible for all patent, trademark, copyright and trade secret matters worldwide. 

Mr. Kappos’s notable matters include representing:

  • Disney in its $85 billion acquisition of 21st Century Fox;
  • Mylan in its $50 billion combination with Upjohn, a division of Pfizer, to form Viatris, and Viatris in its divestitures totaling $6.94 billion in value, including the $3.335 billion combination of its biosimilars portfolio with Biocon Biologics and the divestitures of its Over‑the‑Counter, Women’s Healthcare and Active Pharmaceutical Ingredients businesses, and in its global research and development collaboration with Idorsia;
  • AerCap in its $30 billion acquisition of GE Capital Aviation Services from General Electric;
  • Paramount’s special committee in the $28 billion merger with Skydance;
  • Amazon in its $8.45 billion acquisition of MGM;
  • Brookfield Renewable in its strategic partnership with Cameco to acquire Westinghouse for $8 billion;
  • Illumina in its $8 billion acquisition and subsequent spin‑off of GRAIL, its pending acquisition of SomaLogic and its previous co-development agreement with SomaLogic;
  • Biogen in its $7.3 billion acquisition of Reata Pharmaceuticals, its $1.25 billion settlement and license agreement with Forward Pharma, the expansion of its existing agreement with Eisai to jointly develop and commercialize investigational Alzheimer’s disease treatments and its strategic collaboration agreement with Skyhawk;
  • AmerisourceBergen in its $6.5 billion acquisition of Walgreens’ Alliance Healthcare businesses;
  • Johnson & Johnson in the separation of Kenvue and its $6.5 billion acquisition of Momenta;
  • Scientific Games in the $6.05 billion sale of SG Lottery to Brookfield;
  • The Snyder family in the $6.05 billion sale of the NFL’s Washington Commanders to a partnership led by Josh Harris;
  • HCSC in its $3.3 billion acquisition of Cigna’s Medicare businesses and CareAllies;
  • Roivant Sciences in its $3 billion Strategic Alliance with Sumitomo Dainippon Pharma;
  • The Aquarion Water Authority in its pending $2.4 billion acquisition of Aquarion Water Company from Eversource Energy;
  • WiseTech Global in its $2.1 billion acquisition of e2open, its $414 million acquisition of Blume Global from funds managed by Apollo and EQT and its $230 million acquisition of Envase Technologies from Firmament;
  • Prosus in its $1.8 billion acquisition of Stack Overflow;
  • Bridge Investment Group’s special committee in the pending $1.5 billion acquisition by Apollo;
  • DMGT in the £1.425 billion sale of RMS to Moody's;
  • Paragon 28 in its $1.2 billion acquisition by Zimmer Biomet;
  • Hailey Bieber in the $1 billion acquisition of rhode by e.l.f. Beauty;
  • Light & Wonder in its $850 million acquisition of Grover Charitable Gaming;
  • ZimVie in its pending $730 million acquisition by ARCHIMED and the $375 million sale of its spine business to H.I.G. Capital;
  • Hasbro in the $500 million sale of its eOne Film and TV Business to Lionsgate and in the $385 million sale of eOne Music to Blackstone;
  • Intermex’s strategic alternatives committee in the pending $500 million acquisition by Western Union;
  • Technicolor in the $475 million sale of its Patent Licensing business to InterDigital;
  • Robinhood in its IPO and its $300 million acquisition of TradePMR;
  • Aramex in its $265 million acquisition of MyUS;
  • DRI Capital in the acquisition of a synthetic royalty interest in the worldwide sales of sebetralstat and related equity investment in KalVista Pharmaceuticals, the acquisition from Editas Medicine of payment streams based on the Cas9 gene‑editing technology for CASGEVY, its acquisition of a royalty interest in Orserdu from Eisai, its acquisition of a second royalty interest in Orserdu from Radius Health and the $210 million sale of its TZIELD royalty interest to Sanofi;
  • Ashland in the sale of its nutraceuticals business to Turnspire Capital Partners;
  • Blue Current in its investment from Koch Strategic Platforms;
  • CardWorks in its acquisition of Ally’s credit card business;
  • Costamare in the spin-off of Costamare Bulkers;
  • Fitch Learning, a subsidiary of Hearst, in its pending acquisition of Moody’s Analytics Learning Solutions and the Canadian Securities Institute;
  • Just Eat Takeaway.com in the sale of Grubhub to Wonder;
  • Montana Technologies in its joint venture with GE Vernova;
  • Pitney Bowes in the sale of Borderfree to Global‑e;
  • Qualcomm in the commercial terms of its settlement of global litigation with Apple, including a global six‑year patent license agreement and a multiyear chipset supply agreement;
  • Quibi in its sale to Roku;
  • RedHill Biopharma in its acquisition of Movantik from AstraZeneca and in its agreement with HealthCare Royalty to extinguish its debt obligations in exchange for Movantik;
  • RELX Group in its acquisition of Interfolio; and
  • Taro in its acquisition of Alchemee, formerly The Proactiv Company, from Galderma.

Mr. Kappos has received numerous accolades for his contributions to the field of intellectual property, including, among others, the 2014 Global Agenda Council Vision Award for the Intellectual Property Council’s pro bono initiative from the World Economic Forum, the 2014 Jefferson Medal from the New Jersey Intellectual Property Law Association (NJIPLA), the 2013 Board of Director’s Excellence Award from the American Intellectual Property Law Association (AIPLA), the 2013 Champion of Intellectual Property Award from the District of Columbia Bar Association and the 2013 North America Government Leadership Award from Semiconductor Equipment and Materials International (SEMI). He was also honored as the inaugural recipient of IPWatchdog’s Paul Michel Award in 2021. Mr. Kappos was named one of the “Top 25 Icons of IP” by Law360, one of the “50 Most Influential People in Intellectual Property” and the “Outstanding Practitioner of the Year in IP Transactions” by Managing IP, one of the “Top 50 Intellectual Property Trailblazers & Pioneers” and one of the “100 Most Influential Lawyers in America” by The National Law Journal, “Intellectual Property Professional of the Year” by the Intellectual Property Owners Association and inducted into the Intellectual Property Hall of Fame by Intellectual Asset Management Magazine in 2012. Mr. Kappos was also recognized as a leading lawyer by IAM Global Leaders, IAM Strategy 300, IAM Patent 1000, World IP Review, Chambers USA, The Legal 500 US, Who’s Who Legal: Patents, LMG Life Sciences, Lawdragon, Super Lawyers and The Best Lawyers in America. He is a frequent speaker and has authored many published articles on various intellectual property, innovation and leadership topics.

Mr. Kappos serves on the Boards of Directors of the Partnership for Public Service, the Center for Global Enterprise and the Intellectual Property Owners Education Foundation and on the Advisory Board for C‑IP2. He is the Chair of the Advisory Council of the Naples Roundtable and is a Co‑Chair of the Best Practices in Intellectual Property Conference. He is also an Adjunct Professor at Cornell Law School, where he co‑teaches a class entitled “High Growth Transactions.”

Mr. Kappos was born in Palos Verdes, California. He received a B.S. summa cum laude in Electrical and Computer Engineering from the University of California, Davis in 1983 and a J.D. from the University of California, Berkeley in 1990.

Education

  • J.D., 1990, University of California, Berkeley, School of Law
  • B.S., 1983, University of California, Davis
    summa cum laude

Admitted In

  • New York
  • California
  • District of Columbia

Professional Affiliations

International Bar Association

  • Intellectual Property and Entertainment Law Committee

American Intellectual Property Law Association

  • Amicus Committee

Intellectual Property Owners Association

  • Emeritus Committee

Organizations

Best Practices in Intellectual Property Conference

  • Co-Chair

Center for Global Enterprise

  • Board of Directors

Center for Intellectual Property x Innovation Policy (C-IP2)

  • Advisory Board

Intellectual Property Owners Educational Foundation

  • Board of Directors

Partnership for Public Service

  • Board of Directors

World Economic Forum’s Global Agenda Council on the Economics of Innovation

  • Chair, 2014‑2016

Naples Roundtable

  • Chair of the Advisory Council

Rankings

Best Lawyers in America

  • Biotechnology and Life Sciences Practice (2026, 2025, 2024)
  • Patent Law (2026‑2017)
  • Patent Law: Lawyer of the Year – New York City (2024)

Chambers USA

  • Intellectual Property: Patent: Transactional – New York (2025)

Euromoney Legal Media Group

  • LMG Life Sciences Star - Patent Strategy & Management (2024-2021)
  • LMG Life Sciences Awards - Patent Strategy Attorney of the Year - New York (2022)

Intellectual Asset Management

  • IP Hall of Fame (2012)
  • IAM Global Leaders (2025-2019)
  • IAM Strategy 300 − The World’s Leading IP Strategists (2024‑2014)
  • IAM Patent 1000: The World’s Leading Patent Practitioners (2024‑2014)

Law360

  • Top 25 Icons of IP (2016)

Lawdragon

  • 500 Leading Global Cyber Lawyers (2025, 2024)
  • 500 Leading Lawyers in America (2018‑2013)
  • 500 Leading Global IP Lawyers (2025)
  • Hall of Fame (2019)

The Legal 500 US

  • Fintech (2024-2019)
  • Litigation: Trade Secrets (2014)
  • Patent Litigation: Full Coverage (2019, 2018, 2016, 2014)
  • Technology Transactions (2025‑2013)
  • Telecoms and Broadcast: Transactions (2014)

Managing Intellectual Property

  • Outstanding Practitioner of the Year: IP Transactions (2020)
  • The 50 Most Influential People in IP (2012)

The National Law Journal

  • The 100 Most Influential Lawyers in America (2013)
  • Top 50 Intellectual Property Trailblazers & Pioneers (2014)

Super Lawyers - New York

  • Intellectual Property (2024-2014)

Who’s Who Legal

  • Fintech & Blockchain (2023)
  • IP - Patents (2023-2014)

World IP Review

  • WIPR Leaders (2019-2016)

Board of Director’s Excellence Award, American Intellectual Property Law Association (AIPLA), 2013

Champion of Intellectual Property Award, District of Columbia Bar Association, 2013

IP Professional of the Year Award, Intellectual Property Owners Association, 2011

Jefferson Medal, New Jersey Intellectual Property Law Association (NJIPLA), 2014

Law360 Distinguished Legal Writing Award, The Burton Awards, 2018

North America Government Leadership Award, Semiconductor Equipment and Materials International (SEMI), 2013

Paul Michel Award, IPWatchdog, 2021

Deals & Cases

August 15, 2025

Fitch Learning’s Acquisition of Moody’s Analytics Learning Solutions and the Canadian Securities Institute

On August 14, 2025, Fitch Learning, a global leader in financial learning and professional certifications, announced it signed an agreement with Moody’s to acquire two of their businesses, Moody’s Analytics Learning Solutions, a global provider of credit training, and the Canadian Securities Institute, a leading provider of professional certifications for the Canadian financial services industry. Cravath is representing Fitch Learning in connection with the transaction.

Deals & Cases

August 11, 2025

Intermex’s Acquisition by Western Union

On August 10, 2025, International Money Express, Inc. (“Intermex”) and The Western Union Company (“Western Union”) announced they have entered into a definitive agreement under which Western Union will acquire Intermex in an all‑cash transaction at $16.00 per share, representing a total equity and enterprise value of approximately $500 million. Cravath is representing Intermex’s Strategic Alternatives Committee in connection with the transaction.

Deals & Cases

August 07, 2025

Paramount Global Completes Merger with Skydance

On August 7, 2025, Paramount Global and Skydance Media (“Skydance”) announced the completion of their merger, creating a standalone global media and entertainment company, Paramount, a Skydance Corporation (“Paramount”). Paramount Class B shares will begin trading today on the Nasdaq Stock Market LLC under “PSKY.” Cravath represented the Paramount Special Committee in connection with the transaction.

Deals & Cases

July 21, 2025

ZimVie’s Acquisition by ARCHIMED

On July 21, 2025, ZimVie Inc. (“ZimVie”), a global life sciences leader in the dental implant market, announced their entry into a definitive agreement pursuant to which ZimVie will be acquired by an affiliate of ARCHIMED (“ARCHIMED”), an investment firm focused exclusively on healthcare industries. Under the terms of the merger agreement, ZimVie stockholders will receive $19.00 in cash for each share of ZimVie common stock outstanding at the closing of the transaction, corresponding to an enterprise value of approximately $730 million. Cravath is representing ZimVie in connection with the transaction.

Deals & Cases

June 23, 2025

Illumina’s Acquisition of SomaLogic

On June 23, 2025, Illumina, Inc. (“Illumina”) announced it has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data‑driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance‑based milestones and performance‑based royalties. Cravath is representing Illumina in connection with the transaction.

Activities

August 28, 2025

Dave Kappos Speaks at IPOS’s 2025 Global Forum on Intellectual Property

Cravath partner David J. Kappos participated in the 2025 Global Forum on Intellectual Property, IP Week @ SG 2025, which was hosted by the Intellectual Property Office of Singapore from August 26–27, 2025 in Singapore. Dave spoke on two panels during the forum. The first, entitled “Greening with IP: From Trade Marks to Brands,” explored how trademarks and branding can support sustainability outcomes and addressed legal intricacies related to “going green,” including the risks of greenwashing, building responsible brands and navigating the associated legal landscape. The second panel, entitled “Beyond Battlegrounds: From Territorial Considerations to Strategic Forum Selection,” examined the strategic factors that influence forum selection in IP disputes and provided insights into the comparative advantages of mediation, arbitration and litigation, as well as the use of litigation insurance and third-party funding as tools for financial and risk management.

Publications

August 11, 2025

Cravath Venture Capital & Growth Equity Insights: 2025 Mid‑Year Market Update

On August 11, 2025, Cravath published the latest edition of its Venture Capital & Growth Equity Insights newsletter, which has been redesigned to provide greater insight into global venture capital and related activity during the first half of 2025 and outlook for the rest of the year. Key takeaways from this edition include:

Publications

August 05, 2025

IAM and WTR Publish Article by Dave Kappos on Navigating IP “Landmines” in the Age of AI

On July 31, 2025, Intellectual Asset Management (IAM) and World Trademark Review (WTR) published an article authored by Cravath partner David J. Kappos and associate Callum A.F. Sproule. The article, entitled “Navigating IP Landmines in the Age of AI: What Companies Need to Know” in IAM and “AI and IP: What Companies Need to Know to Avoid Legal Landmines” in WTR, discusses the growing uncertainty surrounding the protectability of AI‑generated content under existing copyright, patent, trademark and trade secret frameworks. It outlines the key legal risks businesses face when using generative AI, including questions of human authorship, enforceability, infringement and data security and offers guidance on how companies can adapt their IP strategies to mitigate exposure.

Publications

July 30, 2025

Oxford Business Law Blog Publishes Article by Dave Kappos Examining Potential Benefits of the UK Joining Europe’s Unified Patent Court

On July 11, 2025, the Oxford Business Law Blog published an article by Cravath partner David J. Kappos entitled “Ten Reasons Why the UK Should Join Europe's Unified Patent Court.” The article examines the potential benefits of the United Kingdom joining the Unified Patent Court, outlining legal, economic and strategic outcomes including increased influence over European patent policy, reduced costs and complexity for UK patentees and enhanced support for innovation infrastructure. 

Activities

July 14, 2025

Dave Kappos Delivers Guest Lecture on IP at Rutgers University

On July 10, 2025, Cravath partner David J. Kappos delivered a guest lecture to students in the Master of Business and Science (“MBS”) program at Rutgers University, as part of the Fundamentals of Intellectual Property class. The course, designed to teach MBS students the practical and strategic foundations of intellectual property, including how to protect, evaluate, negotiate and commercialize IP assets across industries, features guest lectures from scientists, executives and patent attorneys who are experts in the IP field.

David J. Kappos is Co-Chair of the Intellectual Property Practice. He is widely recognized as one of the world’s foremost leaders in the field of intellectual property, including intellectual property management and strategy, the development of global intellectual property norms, laws and practices as well as commercialization and enforcement of innovation‑based assets. Mr. Kappos supports Cravath’s clients with a wide range of their most complex intellectual property issues, including those pertaining to blockchain, cryptoassets and fintech, as well as cybersecurity and data privacy.

From August 2009 to January 2013, Mr. Kappos served as Under Secretary of Commerce and Director of the United States Patent and Trademark Office (USPTO). In that role, he advised the President, the Secretary of Commerce and the Administration on intellectual property policy matters. As Director of the USPTO, he led the Agency in dramatically re‑engineering its entire management and operational systems as well as its engagement with the global innovation community. He was instrumental in achieving the greatest legislative reform of the U.S. patent system in generations through passage and implementation of the Leahy‑Smith America Invents Act, signed into law by President Obama in September 2011.

Prior to leading the USPTO, Mr. Kappos held several executive posts in the legal department of IBM, including litigation counsel, Asia Pacific IP counsel and, from 2003 to 2009, Vice President and Chief Intellectual Property Lawyer responsible for all patent, trademark, copyright and trade secret matters worldwide. 

Mr. Kappos’s notable matters include representing:

  • Disney in its $85 billion acquisition of 21st Century Fox;
  • Mylan in its $50 billion combination with Upjohn, a division of Pfizer, to form Viatris, and Viatris in its divestitures totaling $6.94 billion in value, including the $3.335 billion combination of its biosimilars portfolio with Biocon Biologics and the divestitures of its Over‑the‑Counter, Women’s Healthcare and Active Pharmaceutical Ingredients businesses, and in its global research and development collaboration with Idorsia;
  • AerCap in its $30 billion acquisition of GE Capital Aviation Services from General Electric;
  • Paramount’s special committee in the $28 billion merger with Skydance;
  • Amazon in its $8.45 billion acquisition of MGM;
  • Brookfield Renewable in its strategic partnership with Cameco to acquire Westinghouse for $8 billion;
  • Illumina in its $8 billion acquisition and subsequent spin‑off of GRAIL, its pending acquisition of SomaLogic and its previous co-development agreement with SomaLogic;
  • Biogen in its $7.3 billion acquisition of Reata Pharmaceuticals, its $1.25 billion settlement and license agreement with Forward Pharma, the expansion of its existing agreement with Eisai to jointly develop and commercialize investigational Alzheimer’s disease treatments and its strategic collaboration agreement with Skyhawk;
  • AmerisourceBergen in its $6.5 billion acquisition of Walgreens’ Alliance Healthcare businesses;
  • Johnson & Johnson in the separation of Kenvue and its $6.5 billion acquisition of Momenta;
  • Scientific Games in the $6.05 billion sale of SG Lottery to Brookfield;
  • The Snyder family in the $6.05 billion sale of the NFL’s Washington Commanders to a partnership led by Josh Harris;
  • HCSC in its $3.3 billion acquisition of Cigna’s Medicare businesses and CareAllies;
  • Roivant Sciences in its $3 billion Strategic Alliance with Sumitomo Dainippon Pharma;
  • The Aquarion Water Authority in its pending $2.4 billion acquisition of Aquarion Water Company from Eversource Energy;
  • WiseTech Global in its $2.1 billion acquisition of e2open, its $414 million acquisition of Blume Global from funds managed by Apollo and EQT and its $230 million acquisition of Envase Technologies from Firmament;
  • Prosus in its $1.8 billion acquisition of Stack Overflow;
  • Bridge Investment Group’s special committee in the pending $1.5 billion acquisition by Apollo;
  • DMGT in the £1.425 billion sale of RMS to Moody's;
  • Paragon 28 in its $1.2 billion acquisition by Zimmer Biomet;
  • Hailey Bieber in the $1 billion acquisition of rhode by e.l.f. Beauty;
  • Light & Wonder in its $850 million acquisition of Grover Charitable Gaming;
  • ZimVie in its pending $730 million acquisition by ARCHIMED and the $375 million sale of its spine business to H.I.G. Capital;
  • Hasbro in the $500 million sale of its eOne Film and TV Business to Lionsgate and in the $385 million sale of eOne Music to Blackstone;
  • Intermex’s strategic alternatives committee in the pending $500 million acquisition by Western Union;
  • Technicolor in the $475 million sale of its Patent Licensing business to InterDigital;
  • Robinhood in its IPO and its $300 million acquisition of TradePMR;
  • Aramex in its $265 million acquisition of MyUS;
  • DRI Capital in the acquisition of a synthetic royalty interest in the worldwide sales of sebetralstat and related equity investment in KalVista Pharmaceuticals, the acquisition from Editas Medicine of payment streams based on the Cas9 gene‑editing technology for CASGEVY, its acquisition of a royalty interest in Orserdu from Eisai, its acquisition of a second royalty interest in Orserdu from Radius Health and the $210 million sale of its TZIELD royalty interest to Sanofi;
  • Ashland in the sale of its nutraceuticals business to Turnspire Capital Partners;
  • Blue Current in its investment from Koch Strategic Platforms;
  • CardWorks in its acquisition of Ally’s credit card business;
  • Costamare in the spin-off of Costamare Bulkers;
  • Fitch Learning, a subsidiary of Hearst, in its pending acquisition of Moody’s Analytics Learning Solutions and the Canadian Securities Institute;
  • Just Eat Takeaway.com in the sale of Grubhub to Wonder;
  • Montana Technologies in its joint venture with GE Vernova;
  • Pitney Bowes in the sale of Borderfree to Global‑e;
  • Qualcomm in the commercial terms of its settlement of global litigation with Apple, including a global six‑year patent license agreement and a multiyear chipset supply agreement;
  • Quibi in its sale to Roku;
  • RedHill Biopharma in its acquisition of Movantik from AstraZeneca and in its agreement with HealthCare Royalty to extinguish its debt obligations in exchange for Movantik;
  • RELX Group in its acquisition of Interfolio; and
  • Taro in its acquisition of Alchemee, formerly The Proactiv Company, from Galderma.

Mr. Kappos has received numerous accolades for his contributions to the field of intellectual property, including, among others, the 2014 Global Agenda Council Vision Award for the Intellectual Property Council’s pro bono initiative from the World Economic Forum, the 2014 Jefferson Medal from the New Jersey Intellectual Property Law Association (NJIPLA), the 2013 Board of Director’s Excellence Award from the American Intellectual Property Law Association (AIPLA), the 2013 Champion of Intellectual Property Award from the District of Columbia Bar Association and the 2013 North America Government Leadership Award from Semiconductor Equipment and Materials International (SEMI). He was also honored as the inaugural recipient of IPWatchdog’s Paul Michel Award in 2021. Mr. Kappos was named one of the “Top 25 Icons of IP” by Law360, one of the “50 Most Influential People in Intellectual Property” and the “Outstanding Practitioner of the Year in IP Transactions” by Managing IP, one of the “Top 50 Intellectual Property Trailblazers & Pioneers” and one of the “100 Most Influential Lawyers in America” by The National Law Journal, “Intellectual Property Professional of the Year” by the Intellectual Property Owners Association and inducted into the Intellectual Property Hall of Fame by Intellectual Asset Management Magazine in 2012. Mr. Kappos was also recognized as a leading lawyer by IAM Global Leaders, IAM Strategy 300, IAM Patent 1000, World IP Review, Chambers USA, The Legal 500 US, Who’s Who Legal: Patents, LMG Life Sciences, Lawdragon, Super Lawyers and The Best Lawyers in America. He is a frequent speaker and has authored many published articles on various intellectual property, innovation and leadership topics.

Mr. Kappos serves on the Boards of Directors of the Partnership for Public Service, the Center for Global Enterprise and the Intellectual Property Owners Education Foundation and on the Advisory Board for C‑IP2. He is the Chair of the Advisory Council of the Naples Roundtable and is a Co‑Chair of the Best Practices in Intellectual Property Conference. He is also an Adjunct Professor at Cornell Law School, where he co‑teaches a class entitled “High Growth Transactions.”

Mr. Kappos was born in Palos Verdes, California. He received a B.S. summa cum laude in Electrical and Computer Engineering from the University of California, Davis in 1983 and a J.D. from the University of California, Berkeley in 1990.

From August 2009 to January 2013, Mr. Kappos served as Under Secretary of Commerce and Director of the United States Patent and Trademark Office (USPTO). In that role, he advised the President, the Secretary of Commerce and the Administration on intellectual property policy matters. As Director of the USPTO, he led the Agency in dramatically re‑engineering its entire management and operational systems as well as its engagement with the global innovation community. He was instrumental in achieving the greatest legislative reform of the U.S. patent system in generations through passage and implementation of the Leahy‑Smith America Invents Act, signed into law by President Obama in September 2011.

Prior to leading the USPTO, Mr. Kappos held several executive posts in the legal department of IBM, including litigation counsel, Asia Pacific IP counsel and, from 2003 to 2009, Vice President and Chief Intellectual Property Lawyer responsible for all patent, trademark, copyright and trade secret matters worldwide. 

Mr. Kappos’s notable matters include representing:

  • Disney in its $85 billion acquisition of 21st Century Fox;
  • Mylan in its $50 billion combination with Upjohn, a division of Pfizer, to form Viatris, and Viatris in its divestitures totaling $6.94 billion in value, including the $3.335 billion combination of its biosimilars portfolio with Biocon Biologics and the divestitures of its Over‑the‑Counter, Women’s Healthcare and Active Pharmaceutical Ingredients businesses, and in its global research and development collaboration with Idorsia;
  • AerCap in its $30 billion acquisition of GE Capital Aviation Services from General Electric;
  • Paramount’s special committee in the $28 billion merger with Skydance;
  • Amazon in its $8.45 billion acquisition of MGM;
  • Brookfield Renewable in its strategic partnership with Cameco to acquire Westinghouse for $8 billion;
  • Illumina in its $8 billion acquisition and subsequent spin‑off of GRAIL, its pending acquisition of SomaLogic and its previous co-development agreement with SomaLogic;
  • Biogen in its $7.3 billion acquisition of Reata Pharmaceuticals, its $1.25 billion settlement and license agreement with Forward Pharma, the expansion of its existing agreement with Eisai to jointly develop and commercialize investigational Alzheimer’s disease treatments and its strategic collaboration agreement with Skyhawk;
  • AmerisourceBergen in its $6.5 billion acquisition of Walgreens’ Alliance Healthcare businesses;
  • Johnson & Johnson in the separation of Kenvue and its $6.5 billion acquisition of Momenta;
  • Scientific Games in the $6.05 billion sale of SG Lottery to Brookfield;
  • The Snyder family in the $6.05 billion sale of the NFL’s Washington Commanders to a partnership led by Josh Harris;
  • HCSC in its $3.3 billion acquisition of Cigna’s Medicare businesses and CareAllies;
  • Roivant Sciences in its $3 billion Strategic Alliance with Sumitomo Dainippon Pharma;
  • The Aquarion Water Authority in its pending $2.4 billion acquisition of Aquarion Water Company from Eversource Energy;
  • WiseTech Global in its $2.1 billion acquisition of e2open, its $414 million acquisition of Blume Global from funds managed by Apollo and EQT and its $230 million acquisition of Envase Technologies from Firmament;
  • Prosus in its $1.8 billion acquisition of Stack Overflow;
  • Bridge Investment Group’s special committee in the pending $1.5 billion acquisition by Apollo;
  • DMGT in the £1.425 billion sale of RMS to Moody's;
  • Paragon 28 in its $1.2 billion acquisition by Zimmer Biomet;
  • Hailey Bieber in the $1 billion acquisition of rhode by e.l.f. Beauty;
  • Light & Wonder in its $850 million acquisition of Grover Charitable Gaming;
  • ZimVie in its pending $730 million acquisition by ARCHIMED and the $375 million sale of its spine business to H.I.G. Capital;
  • Hasbro in the $500 million sale of its eOne Film and TV Business to Lionsgate and in the $385 million sale of eOne Music to Blackstone;
  • Intermex’s strategic alternatives committee in the pending $500 million acquisition by Western Union;
  • Technicolor in the $475 million sale of its Patent Licensing business to InterDigital;
  • Robinhood in its IPO and its $300 million acquisition of TradePMR;
  • Aramex in its $265 million acquisition of MyUS;
  • DRI Capital in the acquisition of a synthetic royalty interest in the worldwide sales of sebetralstat and related equity investment in KalVista Pharmaceuticals, the acquisition from Editas Medicine of payment streams based on the Cas9 gene‑editing technology for CASGEVY, its acquisition of a royalty interest in Orserdu from Eisai, its acquisition of a second royalty interest in Orserdu from Radius Health and the $210 million sale of its TZIELD royalty interest to Sanofi;
  • Ashland in the sale of its nutraceuticals business to Turnspire Capital Partners;
  • Blue Current in its investment from Koch Strategic Platforms;
  • CardWorks in its acquisition of Ally’s credit card business;
  • Costamare in the spin-off of Costamare Bulkers;
  • Fitch Learning, a subsidiary of Hearst, in its pending acquisition of Moody’s Analytics Learning Solutions and the Canadian Securities Institute;
  • Just Eat Takeaway.com in the sale of Grubhub to Wonder;
  • Montana Technologies in its joint venture with GE Vernova;
  • Pitney Bowes in the sale of Borderfree to Global‑e;
  • Qualcomm in the commercial terms of its settlement of global litigation with Apple, including a global six‑year patent license agreement and a multiyear chipset supply agreement;
  • Quibi in its sale to Roku;
  • RedHill Biopharma in its acquisition of Movantik from AstraZeneca and in its agreement with HealthCare Royalty to extinguish its debt obligations in exchange for Movantik;
  • RELX Group in its acquisition of Interfolio; and
  • Taro in its acquisition of Alchemee, formerly The Proactiv Company, from Galderma.

Mr. Kappos has received numerous accolades for his contributions to the field of intellectual property, including, among others, the 2014 Global Agenda Council Vision Award for the Intellectual Property Council’s pro bono initiative from the World Economic Forum, the 2014 Jefferson Medal from the New Jersey Intellectual Property Law Association (NJIPLA), the 2013 Board of Director’s Excellence Award from the American Intellectual Property Law Association (AIPLA), the 2013 Champion of Intellectual Property Award from the District of Columbia Bar Association and the 2013 North America Government Leadership Award from Semiconductor Equipment and Materials International (SEMI). He was also honored as the inaugural recipient of IPWatchdog’s Paul Michel Award in 2021. Mr. Kappos was named one of the “Top 25 Icons of IP” by Law360, one of the “50 Most Influential People in Intellectual Property” and the “Outstanding Practitioner of the Year in IP Transactions” by Managing IP, one of the “Top 50 Intellectual Property Trailblazers & Pioneers” and one of the “100 Most Influential Lawyers in America” by The National Law Journal, “Intellectual Property Professional of the Year” by the Intellectual Property Owners Association and inducted into the Intellectual Property Hall of Fame by Intellectual Asset Management Magazine in 2012. Mr. Kappos was also recognized as a leading lawyer by IAM Global Leaders, IAM Strategy 300, IAM Patent 1000, World IP Review, Chambers USA, The Legal 500 US, Who’s Who Legal: Patents, LMG Life Sciences, Lawdragon, Super Lawyers and The Best Lawyers in America. He is a frequent speaker and has authored many published articles on various intellectual property, innovation and leadership topics.

Mr. Kappos serves on the Boards of Directors of the Partnership for Public Service, the Center for Global Enterprise and the Intellectual Property Owners Education Foundation and on the Advisory Board for C‑IP2. He is the Chair of the Advisory Council of the Naples Roundtable and is a Co‑Chair of the Best Practices in Intellectual Property Conference. He is also an Adjunct Professor at Cornell Law School, where he co‑teaches a class entitled “High Growth Transactions.”

Mr. Kappos was born in Palos Verdes, California. He received a B.S. summa cum laude in Electrical and Computer Engineering from the University of California, Davis in 1983 and a J.D. from the University of California, Berkeley in 1990.

Education

  • J.D., 1990, University of California, Berkeley, School of Law
  • B.S., 1983, University of California, Davis
    summa cum laude

Admitted In

  • New York
  • California
  • District of Columbia

Professional Affiliations

International Bar Association

  • Intellectual Property and Entertainment Law Committee

American Intellectual Property Law Association

  • Amicus Committee

Intellectual Property Owners Association

  • Emeritus Committee

Organizations

Best Practices in Intellectual Property Conference

  • Co-Chair

Center for Global Enterprise

  • Board of Directors

Center for Intellectual Property x Innovation Policy (C-IP2)

  • Advisory Board

Intellectual Property Owners Educational Foundation

  • Board of Directors

Partnership for Public Service

  • Board of Directors

World Economic Forum’s Global Agenda Council on the Economics of Innovation

  • Chair, 2014‑2016

Naples Roundtable

  • Chair of the Advisory Council

Rankings

Best Lawyers in America

  • Biotechnology and Life Sciences Practice (2026, 2025, 2024)
  • Patent Law (2026‑2017)
  • Patent Law: Lawyer of the Year – New York City (2024)

Chambers USA

  • Intellectual Property: Patent: Transactional – New York (2025)

Euromoney Legal Media Group

  • LMG Life Sciences Star - Patent Strategy & Management (2024-2021)
  • LMG Life Sciences Awards - Patent Strategy Attorney of the Year - New York (2022)

Intellectual Asset Management

  • IP Hall of Fame (2012)
  • IAM Global Leaders (2025-2019)
  • IAM Strategy 300 − The World’s Leading IP Strategists (2024‑2014)
  • IAM Patent 1000: The World’s Leading Patent Practitioners (2024‑2014)

Law360

  • Top 25 Icons of IP (2016)

Lawdragon

  • 500 Leading Global Cyber Lawyers (2025, 2024)
  • 500 Leading Lawyers in America (2018‑2013)
  • 500 Leading Global IP Lawyers (2025)
  • Hall of Fame (2019)

The Legal 500 US

  • Fintech (2024-2019)
  • Litigation: Trade Secrets (2014)
  • Patent Litigation: Full Coverage (2019, 2018, 2016, 2014)
  • Technology Transactions (2025‑2013)
  • Telecoms and Broadcast: Transactions (2014)

Managing Intellectual Property

  • Outstanding Practitioner of the Year: IP Transactions (2020)
  • The 50 Most Influential People in IP (2012)

The National Law Journal

  • The 100 Most Influential Lawyers in America (2013)
  • Top 50 Intellectual Property Trailblazers & Pioneers (2014)

Super Lawyers - New York

  • Intellectual Property (2024-2014)

Who’s Who Legal

  • Fintech & Blockchain (2023)
  • IP - Patents (2023-2014)

World IP Review

  • WIPR Leaders (2019-2016)

Board of Director’s Excellence Award, American Intellectual Property Law Association (AIPLA), 2013

Champion of Intellectual Property Award, District of Columbia Bar Association, 2013

IP Professional of the Year Award, Intellectual Property Owners Association, 2011

Jefferson Medal, New Jersey Intellectual Property Law Association (NJIPLA), 2014

Law360 Distinguished Legal Writing Award, The Burton Awards, 2018

North America Government Leadership Award, Semiconductor Equipment and Materials International (SEMI), 2013

Paul Michel Award, IPWatchdog, 2021

Deals & Cases

August 15, 2025

Fitch Learning’s Acquisition of Moody’s Analytics Learning Solutions and the Canadian Securities Institute

On August 14, 2025, Fitch Learning, a global leader in financial learning and professional certifications, announced it signed an agreement with Moody’s to acquire two of their businesses, Moody’s Analytics Learning Solutions, a global provider of credit training, and the Canadian Securities Institute, a leading provider of professional certifications for the Canadian financial services industry. Cravath is representing Fitch Learning in connection with the transaction.

Deals & Cases

August 11, 2025

Intermex’s Acquisition by Western Union

On August 10, 2025, International Money Express, Inc. (“Intermex”) and The Western Union Company (“Western Union”) announced they have entered into a definitive agreement under which Western Union will acquire Intermex in an all‑cash transaction at $16.00 per share, representing a total equity and enterprise value of approximately $500 million. Cravath is representing Intermex’s Strategic Alternatives Committee in connection with the transaction.

Deals & Cases

August 07, 2025

Paramount Global Completes Merger with Skydance

On August 7, 2025, Paramount Global and Skydance Media (“Skydance”) announced the completion of their merger, creating a standalone global media and entertainment company, Paramount, a Skydance Corporation (“Paramount”). Paramount Class B shares will begin trading today on the Nasdaq Stock Market LLC under “PSKY.” Cravath represented the Paramount Special Committee in connection with the transaction.

Deals & Cases

July 21, 2025

ZimVie’s Acquisition by ARCHIMED

On July 21, 2025, ZimVie Inc. (“ZimVie”), a global life sciences leader in the dental implant market, announced their entry into a definitive agreement pursuant to which ZimVie will be acquired by an affiliate of ARCHIMED (“ARCHIMED”), an investment firm focused exclusively on healthcare industries. Under the terms of the merger agreement, ZimVie stockholders will receive $19.00 in cash for each share of ZimVie common stock outstanding at the closing of the transaction, corresponding to an enterprise value of approximately $730 million. Cravath is representing ZimVie in connection with the transaction.

Deals & Cases

June 23, 2025

Illumina’s Acquisition of SomaLogic

On June 23, 2025, Illumina, Inc. (“Illumina”) announced it has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data‑driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance‑based milestones and performance‑based royalties. Cravath is representing Illumina in connection with the transaction.

Activities

August 28, 2025

Dave Kappos Speaks at IPOS’s 2025 Global Forum on Intellectual Property

Cravath partner David J. Kappos participated in the 2025 Global Forum on Intellectual Property, IP Week @ SG 2025, which was hosted by the Intellectual Property Office of Singapore from August 26–27, 2025 in Singapore. Dave spoke on two panels during the forum. The first, entitled “Greening with IP: From Trade Marks to Brands,” explored how trademarks and branding can support sustainability outcomes and addressed legal intricacies related to “going green,” including the risks of greenwashing, building responsible brands and navigating the associated legal landscape. The second panel, entitled “Beyond Battlegrounds: From Territorial Considerations to Strategic Forum Selection,” examined the strategic factors that influence forum selection in IP disputes and provided insights into the comparative advantages of mediation, arbitration and litigation, as well as the use of litigation insurance and third-party funding as tools for financial and risk management.

Publications

August 11, 2025

Cravath Venture Capital & Growth Equity Insights: 2025 Mid‑Year Market Update

On August 11, 2025, Cravath published the latest edition of its Venture Capital & Growth Equity Insights newsletter, which has been redesigned to provide greater insight into global venture capital and related activity during the first half of 2025 and outlook for the rest of the year. Key takeaways from this edition include:

Publications

August 05, 2025

IAM and WTR Publish Article by Dave Kappos on Navigating IP “Landmines” in the Age of AI

On July 31, 2025, Intellectual Asset Management (IAM) and World Trademark Review (WTR) published an article authored by Cravath partner David J. Kappos and associate Callum A.F. Sproule. The article, entitled “Navigating IP Landmines in the Age of AI: What Companies Need to Know” in IAM and “AI and IP: What Companies Need to Know to Avoid Legal Landmines” in WTR, discusses the growing uncertainty surrounding the protectability of AI‑generated content under existing copyright, patent, trademark and trade secret frameworks. It outlines the key legal risks businesses face when using generative AI, including questions of human authorship, enforceability, infringement and data security and offers guidance on how companies can adapt their IP strategies to mitigate exposure.

Publications

July 30, 2025

Oxford Business Law Blog Publishes Article by Dave Kappos Examining Potential Benefits of the UK Joining Europe’s Unified Patent Court

On July 11, 2025, the Oxford Business Law Blog published an article by Cravath partner David J. Kappos entitled “Ten Reasons Why the UK Should Join Europe's Unified Patent Court.” The article examines the potential benefits of the United Kingdom joining the Unified Patent Court, outlining legal, economic and strategic outcomes including increased influence over European patent policy, reduced costs and complexity for UK patentees and enhanced support for innovation infrastructure. 

Activities

July 14, 2025

Dave Kappos Delivers Guest Lecture on IP at Rutgers University

On July 10, 2025, Cravath partner David J. Kappos delivered a guest lecture to students in the Master of Business and Science (“MBS”) program at Rutgers University, as part of the Fundamentals of Intellectual Property class. The course, designed to teach MBS students the practical and strategic foundations of intellectual property, including how to protect, evaluate, negotiate and commercialize IP assets across industries, features guest lectures from scientists, executives and patent attorneys who are experts in the IP field.

Cravath Bicentennial

Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

Explore

Cravath, Swaine & Moore LLP Logo
  • CONTACT US
  • OUR STORY
  • ALUMNI PORTAL
  • DISCLAIMERS & NOTICES

Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.